[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA201309171B - Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors - Google Patents

Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors

Info

Publication number
ZA201309171B
ZA201309171B ZA2013/09171A ZA201309171A ZA201309171B ZA 201309171 B ZA201309171 B ZA 201309171B ZA 2013/09171 A ZA2013/09171 A ZA 2013/09171A ZA 201309171 A ZA201309171 A ZA 201309171A ZA 201309171 B ZA201309171 B ZA 201309171B
Authority
ZA
South Africa
Prior art keywords
bace1
oxazines
halogen
alkyl
bace2 inhibitors
Prior art date
Application number
ZA2013/09171A
Inventor
Thomas Woltering
Original Assignee
Hoffmann La Roche
Siena Biotech Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Siena Biotech Spa filed Critical Hoffmann La Roche
Publication of ZA201309171B publication Critical patent/ZA201309171B/en

Links

ZA2013/09171A 2011-06-07 2013-12-05 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors ZA201309171B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11169007 2011-06-07
EP2012030457 2012-06-04

Publications (1)

Publication Number Publication Date
ZA201309171B true ZA201309171B (en) 2016-08-31

Family

ID=60971804

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/09171A ZA201309171B (en) 2011-06-07 2013-12-05 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors

Country Status (1)

Country Link
ZA (1) ZA201309171B (en)

Similar Documents

Publication Publication Date Title
IL228104A0 (en) 1,3 oxazines as bace1 and/or bace2 inhibitors
IL229686A0 (en) Halogen -alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
HK1187915A1 (en) 1,4 oxazines as bace1 and/or bace2 inhibitors bace1 / bace2 14
ZA201308400B (en) 1,3-oxazines as bace1 and/or bace2 inhibitors
IL229334A (en) Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
HK1210609A1 (en) Fluoro-[1,3]oxazines as bace1 inhibitors bace1 -[13]
IL269322B (en) Methylphenidate-prodrugs, processes of making and using the same
BR112013016360A2 (en) 1,4 oxazines as inhibitors of bace1 and / or bace2
EP2747769A4 (en) 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
EP2697210A4 (en) 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions, and their use
SG11201406123TA (en) 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS
EP2703399A4 (en) Oxazine derivative and bace 1 inhibitor containing same
HK1190701A1 (en) N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]- amides as bace1 and/or bace2 inhibitors bace1 / bace2 n-[3-(5--33a77a--1h-24-- 6---7-)-]-
IL228641A0 (en) Combinations of akt inhibitor compounds and erlotinib, and methods of use
BR112013020019A2 (en) 1,4-oxazepines as inhibitors of bace1 and / or bace2.
IL232764A0 (en) Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines
EP2729464B8 (en) Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors
IL235681A (en) 5-amino[1,4]thiazines as bace1 inhibitors
IL236138A (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
GB201108825D0 (en) Morpholino compounds, uses and methods
IL229262A0 (en) Superstructure and methods for manufacturing the same
ZA201306613B (en) Combinations comprising macitentan for the treatment of glioblastoma multiforme
ZA201309171B (en) Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
ZA201306276B (en) Sporulation-deficient b.texasporus cells and methods for efficient and cost-effective inactivation and use thereof
GB201120494D0 (en) Modified exonuclease